Trials / Completed
CompletedNCT04944927
HEmiplegia Arrhythmia Retrospective Trial
Role of Alternating Hemiplegia of Childhood Genotype in Cardiac Repolarization. HEART: HEmiplegia Arrhythmia Retrospective Trial
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 20 (actual)
- Sponsor
- Hospices Civils de Lyon · Academic / Other
- Sex
- All
- Age
- 12 Months
- Healthy volunteers
- Not accepted
Summary
Alternating Hemiplegia of Childhood (AHC) is a rare and severe disease that is in need of effective, and hopefully even curative, therapies. Afflicted patients suffer from severe paralyzing crises, often excruciatingly painful muscle spasms, severe often life threatening epileptic seizures, frequently severe developmental and psychiatric/psychological disabilities and other comorbidities, such as cardiac disturbances. Recent data indicate that AHC genotype is in relation to cardiac repolarization troubles and to cardiac arrhythmias. The primary hypothesis to explore is that there is an association between genotype and cardiac phenotype in AHC.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Recording of clinical parameters and electrocardiogram parameters | Retrospective recording of demographic information (age, sex, age at diagnosis), genetic information, cardiological information, pharmacological treatments, electrocardiogram data. All above data will be deidentified. |
Timeline
- Start date
- 2021-04-29
- Primary completion
- 2021-12-29
- Completion
- 2022-06-29
- First posted
- 2021-06-30
- Last updated
- 2023-02-22
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04944927. Inclusion in this directory is not an endorsement.